𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Squamous cell carcinoma antigen in the diagnosis and treatment follow-up of oral and facial squamous cell carcinoma

✍ Scribed by Wolfgang Fischbach; Thomas Meyer; Klaus Barthel


Publisher
John Wiley and Sons
Year
1990
Tongue
English
Weight
367 KB
Volume
65
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Basaloid squamous cell carcinoma of the
✍ Mario Sarbia; Patrick Verreet; Fernando Bittinger; Philipp Dutkowski; HansjΓΆrg H πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 468 KB πŸ‘ 2 views

## BACKGROUND. Basaloid squamous cell carcinoma (BSCC) is a recently recognized, Mario Sarbia, M.D

Expression of EMMPRIN by oral squamous c
✍ Leonardo C. Bordador; Xiaowu Li; Bryan Toole; Bing Chen; Joseph Regezi; Luciano πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 French βš– 294 KB πŸ‘ 1 views

A transmembrane glycoprotein recently identified on some tumor cells, extracellular matrix metalloproteinase inducer (EMMPRIN), has been shown to induce metalloproteinase (MMP) production by peritumor fibroblasts (PTF). We examined biopsy specimens of normal human oral mucosa and oral squamous cell

Salvage treatment for recurrent squamous
✍ Glenn J. Schwartz; Rajeev H. Mehta; Barry L. Wenig; Chitra Shaligram; Louis G. P πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 140 KB πŸ‘ 1 views

Background. Squamous cell carcinoma (SCCA) of the oral cavity recurs with a frequency of 25%-48%, a fact that usually portends a poor prognosis. Recent studies have reported salvage cure rates as high as 67%. Investigators have also claimed that restaging recurrent tumors provides useful prognostic